Teva Pharmaceutical Industries Ltd

Arrowpoint Investment Partners (Singapore) Pte. Ltd. TEVA
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
81,993
Value ($000)
2,778
Weight
0.6%
2025 Q4 - 2026 Q2 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).